| 70121-1732-09 | Ropivacaine HClAmneal Pharmaceuticals, LLC | 100 × 24 | 200 | 4,800 | $192.00 | ASP | Q3 2024 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 70121-1733-09 | Ropivacaine HClAmneal Pharmaceuticals, LLC | 200 × 24 | 400 | 9,600 | $384.00 | ASP | Q3 2024 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 70121-1734-03 | Ropivacaine HClAmneal Pharmaceuticals, LLC | 100 × 12 | 500 | 6,000 | $240.00 | ASP | Q4 2024 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 72485-0519-10 | Ropivacaine HClArmas Pharmaceuticals Inc. | 30 × 10 | 150 | 1,500 | $60.00 | ASP | Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 43066-0015-10 | RopivacaineBaxter Healthcare Corporation | 20 × 10 | 40 | 400 | $16.00 | ASP | Q2 2021 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 43066-0019-10 | RopivacaineBaxter Healthcare Corporation | 20 × 10 | 100 | 1,000 | $40.00 | ASP | Q2 2021 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 43066-0023-10 | RopivacaineBaxter Healthcare Corporation | 30 × 10 | 150 | 1,500 | $60.00 | ASP | Q2 2021 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 43066-0027-10 | RopivacaineBaxter Healthcare Corporation | 20 × 10 | 200 | 2,000 | $80.00 | ASP | Q2 2021 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 43066-0152-10 | RopivacaineBaxter Healthcare Corporation | 100 × 10 | 200 | 2,000 | $80.00 | ASP | Q3 2024 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 43066-0154-10 | RopivacaineBaxter Healthcare Corporation | 200 × 10 | 400 | 4,000 | $160.00 | ASP | Q3 2024 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 65145-0107-10 | Ropivacaine HClCaplin Steriles USA Inc. | 20 × 10 | 40 | 400 | $16.00 | ASP | Q3 2025 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 65145-0108-10 | Ropivacaine HClCaplin Steriles USA Inc. | 20 × 10 | 100 | 1,000 | $40.00 | ASP | Q3 2025 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 65145-0109-10 | Ropivacaine HClCaplin Steriles USA Inc. | 30 × 10 | 150 | 1,500 | $60.00 | ASP | Q3 2025 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 65145-0110-10 | Ropivacaine HClCaplin Steriles USA Inc. | 20 × 10 | 200 | 2,000 | $80.00 | ASP | Q3 2025 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 65145-0165-01 | Ropivacaine HClCaplin Steriles USA Inc. | 100 × 1 | 200 | 200 | $8.00 | ASP | Q3 2025 – Q4 2026 | Not found |
|---|
| 65145-0165-10 | Ropivacaine HClCaplin Steriles USA Inc. | 100 × 10 | 200 | 2,000 | $80.00 | ASP | Q1 2026 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 72572-0707-10 | Ropivacaine HClCivica, Inc. | 30 × 10 | 150 | 1,500 | $60.00 | ASP | Q3 2023 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 55150-0195-20 | RopivacaineEugia US LLC | 20 × 25 | 40 | 1,000 | $40.00 | ASP | Q1 2021 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 55150-0196-99 | RopivacaineEugia US LLC | 100 × 1 | 200 | 200 | $8.00 | ASP | Q1 2021 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 55150-0197-20 | RopivacaineEugia US LLC | 20 × 25 | 100 | 2,500 | $100.00 | ASP | Q1 2021 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 55150-0198-30 | RopivacaineEugia US LLC | 30 × 25 | 150 | 3,750 | $150.00 | ASP | Q1 2021 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 55150-0199-20 | RopivacaineEugia US LLC | 20 × 25 | 150 | 3,750 | $150.00 | ASP | Q1 2021 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 55150-0200-10 | RopivacaineEugia US LLC | 10 × 25 | 100 | 2,500 | $100.00 | ASP | Q1 2021 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 55150-0201-20 | RopivacaineEugia US LLC | 20 × 25 | 200 | 5,000 | $200.00 | ASP | Q1 2021 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 63323-0285-10 | NaropinFreseniUS Kabi USA, LLC | 10 × 5 | 20 | 100 | $4.00 | ASP | Q1 2021 – Q4 2026 | ListedNaropin |
|---|
| 63323-0285-13 | NaropinFreseniUS Kabi USA, LLC | 10 × 25 | 20 | 500 | $20.00 | ASP | Q1 2021 – Q4 2026 | ListedNaropin |
|---|
| 63323-0285-20 | NaropinFreseniUS Kabi USA, LLC | 20 × 5 | 40 | 200 | $8.00 | ASP | Q1 2021 – Q4 2026 | ListedNaropin |
|---|
| 63323-0285-23 | NaropinFreseniUS Kabi USA, LLC | 20 × 25 | 40 | 1,000 | $40.00 | ASP | Q1 2021 – Q4 2026 | ListedNaropin |
|---|
| 63323-0285-28 | NaropinFreseniUS Kabi USA, LLC | 20 × 25 | 40 | 1,000 | $40.00 | ASP | Q1 2021 – Q4 2026 | ListedNaropin |
|---|
| 63323-0285-61 | NaropinFreseniUS Kabi USA, LLC | 100 × 24 | 200 | 4,800 | $192.00 | ASP | Q1 2021 – Q4 2026 | ListedNaropin |
|---|
| 63323-0285-63 | NaropinFreseniUS Kabi USA, LLC | 200 × 24 | 400 | 9,600 | $384.00 | ASP | Q1 2021 – Q4 2026 | ListedNaropin |
|---|
| 63323-0285-64 | NaropinFreseniUS Kabi USA, LLC | 200 × 12 | 400 | 4,800 | $192.00 | ASP | Q1 2021 – Q4 2026 | ListedNaropin |
|---|
| 63323-0285-65 | NaropinFreseniUS Kabi USA, LLC | 100 × 12 | 200 | 2,400 | $96.00 | ASP | Q1 2021 – Q4 2026 | ListedNaropin |
|---|
| 63323-0285-67 | NaropinFreseniUS Kabi USA, LLC | 100 × 12 | 200 | 2,400 | $96.00 | ASP | Q1 2021 – Q4 2026 | ListedNaropin |
|---|
| 63323-0285-68 | NaropinFreseniUS Kabi USA, LLC | 100 × 12 | 200 | 2,400 | $96.00 | ASP | Q1 2021 – Q4 2026 | ListedNaropin |
|---|
| 63323-0285-73 | NaropinFreseniUS Kabi USA, LLC | 200 × 12 | 400 | 4,800 | $192.00 | ASP | Q1 2021 – Q4 2026 | ListedNaropin |
|---|
| 63323-0286-00 | NaropinFreseniUS Kabi USA, LLC | 100 × 12 | 500 | 6,000 | $240.00 | ASP | Q1 2021 – Q4 2026 | ListedNaropin |
|---|
| 63323-0286-20 | NaropinFreseniUS Kabi USA, LLC | 20 × 5 | 100 | 500 | $20.00 | ASP | Q1 2021 – Q4 2026 | ListedNaropin |
|---|
| 63323-0286-23 | NaropinFreseniUS Kabi USA, LLC | 20 × 25 | 100 | 2,500 | $100.00 | ASP | Q1 2021 – Q4 2026 | ListedNaropin |
|---|
| 63323-0286-27 | NaropinFreseniUS Kabi USA, LLC | 20 × 25 | 100 | 2,500 | $100.00 | ASP | Q1 2021 – Q4 2026 | ListedNaropin |
|---|
| 63323-0286-35 | NaropinFreseniUS Kabi USA, LLC | 30 × 25 | 150 | 3,750 | $150.00 | ASP | Q1 2021 – Q4 2026 | ListedNaropin |
|---|
| 63323-0286-38 | NaropinFreseniUS Kabi USA, LLC | 30 × 25 | 150 | 3,750 | $150.00 | ASP | Q1 2021 – Q4 2026 | ListedNaropin |
|---|
| 63323-0286-63 | NaropinFreseniUS Kabi USA, LLC | 200 × 12 | 1,000 | 12,000 | $480.00 | ASP | Q1 2021 – Q4 2026 | ListedNaropin |
|---|
| 63323-0286-95 | NaropinFreseniUS Kabi USA, LLC | 30 × 25 | 150 | 3,750 | $150.00 | ASP | Q1 2021 – Q4 2026 | ListedNaropin |
|---|
| 63323-0287-20 | NaropinFreseniUS Kabi USA, LLC | 20 × 5 | 150 | 750 | $30.00 | ASP | Q1 2021 – Q4 2026 | ListedNaropin |
|---|
| 63323-0287-21 | NaropinFreseniUS Kabi USA, LLC | 20 × 25 | 150 | 3,750 | $150.00 | ASP | Q1 2021 – Q4 2026 | ListedNaropin |
|---|
| 63323-0288-10 | NaropinFreseniUS Kabi USA, LLC | 10 × 5 | 100 | 500 | $20.00 | ASP | Q1 2021 – Q4 2026 | ListedNaropin |
|---|
| 63323-0288-11 | NaropinFreseniUS Kabi USA, LLC | 10 × 25 | 100 | 2,500 | $100.00 | ASP | Q1 2021 – Q4 2026 | ListedNaropin |
|---|
| 63323-0288-20 | NaropinFreseniUS Kabi USA, LLC | 20 × 5 | 200 | 1,000 | $40.00 | ASP | Q1 2021 – Q4 2026 | ListedNaropin |
|---|
| 63323-0288-21 | NaropinFreseniUS Kabi USA, LLC | 20 × 25 | 200 | 5,000 | $200.00 | ASP | Q1 2021 – Q4 2026 | ListedNaropin |
|---|
| 63323-0288-27 | NaropinFreseniUS Kabi USA, LLC | 20 × 5 | 200 | 1,000 | $40.00 | ASP | Q1 2021 – Q4 2026 | ListedNaropin |
|---|
| 63323-0288-29 | NaropinFreseniUS Kabi USA, LLC | 20 × 25 | 200 | 5,000 | $200.00 | ASP | Q1 2021 – Q4 2026 | ListedNaropin |
|---|
| 65219-0632-10 | Ropivacaine HClFreseniUS Kabi USA, LLC | 100 × 24 | 200 | 4,800 | $192.00 | ASP | Q3 2025 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 65219-0632-20 | Ropivacaine HClFreseniUS Kabi USA, LLC | 200 × 24 | 400 | 9,600 | $384.00 | ASP | Q3 2025 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 68462-0778-55 | Ropivacaine HClGlenmark Pharmaceuticals Inc., Usa | 20 × 25 | 100 | 2,500 | $100.00 | ASP | Q2 2026 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 68462-0778-74 | Ropivacaine HClGlenmark Pharmaceuticals Inc., Usa | 20 × 10 | 100 | 1,000 | $40.00 | ASP | Q2 2026 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 68462-0793-55 | Ropivacaine HClGlenmark Pharmaceuticals Inc., Usa | 20 × 25 | 40 | 1,000 | $40.00 | ASP | Q2 2026 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 68462-0793-74 | Ropivacaine HClGlenmark Pharmaceuticals Inc., Usa | 20 × 10 | 40 | 400 | $16.00 | ASP | Q2 2026 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 68462-0794-62 | Ropivacaine HClGlenmark Pharmaceuticals Inc., Usa | 30 × 25 | 150 | 3,750 | $150.00 | ASP | Q2 2026 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 68462-0794-84 | Ropivacaine HClGlenmark Pharmaceuticals Inc., Usa | 30 × 10 | 150 | 1,500 | $60.00 | ASP | Q2 2026 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 68462-0795-55 | Ropivacaine HClGlenmark Pharmaceuticals Inc., Usa | 20 × 25 | 200 | 5,000 | $200.00 | ASP | Q2 2026 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 68462-0777-35 | Ropivacaine HClGlenmark Pharmaceuticals Inc., USA | 10 × 25 | 20 | 500 | $20.00 | ASP | Q3 2026 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 00404-9924-30 | NaropinHenry Schein Inc. | 30 × 1 | 150 | 150 | $6.00 | ASP | Q3 2023 – Q4 2026 | ListedNaropin |
|---|
| 52584-0286-35 | Ropivacaine HClHenry Schein Inc. | 30 × 1 | 150 | 150 | $6.00 | ASP | Q1 2025 – Q4 2026 | Excluded listingNaropin |
|---|
| 00143-9195-24 | Ropivacaine HClHikma Pharmaceuticals USA Inc. | 100 × 24 | 200 | 4,800 | $192.00 | ASP | Q2 2026 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 00143-9263-10 | RopivacaineHikma Pharmaceuticals USA Inc. | 20 × 10 | 40 | 400 | $16.00 | ASP | Q2 2021 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 00143-9264-10 | Ropivacaine HClHikma Pharmaceuticals USA Inc. | 30 × 10 | 150 | 1,500 | $60.00 | ASP | Q3 2026 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 00143-9265-10 | Ropivacaine HClHikma Pharmaceuticals USA Inc. | 20 × 10 | 150 | 1,500 | $60.00 | ASP | Q2 2026 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 00143-9266-10 | Ropivacaine HClHikma Pharmaceuticals USA Inc. | 20 × 10 | 200 | 2,000 | $80.00 | ASP | Q3 2026 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 71288-0732-11 | Ropivacaine HClMeitheal Pharmaceuticals Inc. | 10 × 25 | 20 | 500 | $20.00 | ASP | Q2 2025 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 71288-0733-21 | Ropivacaine HClMeitheal Pharmaceuticals Inc. | 20 × 25 | 40 | 1,000 | $40.00 | ASP | Q2 2025 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 71288-0734-21 | Ropivacaine HClMeitheal Pharmaceuticals Inc. | 20 × 25 | 100 | 2,500 | $100.00 | ASP | Q2 2025 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 71288-0735-31 | Ropivacaine HClMeitheal Pharmaceuticals Inc. | 30 × 25 | 150 | 3,750 | $150.00 | ASP | Q2 2025 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 71288-0736-21 | Ropivacaine HClMeitheal Pharmaceuticals Inc. | 20 × 25 | 150 | 3,750 | $150.00 | ASP | Q2 2025 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 71288-0737-11 | Ropivacaine HClMeitheal Pharmaceuticals Inc. | 10 × 25 | 100 | 2,500 | $100.00 | ASP | Q2 2025 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 71288-0738-21 | Ropivacaine HClMeitheal Pharmaceuticals Inc. | 20 × 25 | 200 | 5,000 | $200.00 | ASP | Q2 2025 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 67457-0798-99 | Ropivacaine HClMylan Institutional LLC | 100 × 10 | 200 | 2,000 | $80.00 | ASP | Q3 2024 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 67457-0799-99 | Ropivacaine HClMylan Institutional LLC | 200 × 10 | 400 | 4,000 | $160.00 | ASP | Q3 2024 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 72603-0218-25 | Ropivacaine HClNorthstar RxLLC | 30 × 25 | 150 | 3,750 | $150.00 | ASP | Q1 2026 – Q4 2026 | Excluded listingRopivacaine Hydrochloride |
|---|
| 72603-0219-25 | Ropivacaine HClNorthstar RxLLC | 20 × 25 | 200 | 5,000 | $200.00 | ASP | Q1 2026 – Q4 2026 | Excluded listingRopivacaine Hydrochloride |
|---|
| 25021-0652-82 | RopivacaineSagent Pharmaceuticals | 100 × 10 | 500 | 5,000 | $200.00 | ASP | Q1 2021 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 25021-0652-87 | RopivacaineSagent Pharmaceuticals | 200 × 10 | 1,000 | 10,000 | $400.00 | ASP | Q1 2021 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 25021-0671-66 | RopivacaineSagent Pharmaceuticals | 100 × 10 | 200 | 2,000 | $80.00 | ASP | Q1 2021 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 25021-0671-67 | RopivacaineSagent Pharmaceuticals | 200 × 10 | 400 | 4,000 | $160.00 | ASP | Q1 2021 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 25021-0671-82 | RopivacaineSagent Pharmaceuticals | 100 × 10 | 200 | 2,000 | $80.00 | ASP | Q1 2021 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 25021-0671-87 | RopivacaineSagent Pharmaceuticals | 200 × 10 | 400 | 4,000 | $160.00 | ASP | Q1 2021 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 70512-0797-24 | Ropivacaine HClSola Pharmaceuticals | 100 × 24 | 200 | 4,800 | $192.00 | ASP | Q1 2026 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 70512-0798-24 | Ropivacaine HClSola Pharmaceuticals | 200 × 24 | 400 | 9,600 | $384.00 | ASP | Q1 2026 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 70069-0061-10 | Ropivacaine HClSomerset Pharma, LLC | 10 × 10 | 20 | 200 | $8.00 | ASP | Q1 2026 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 70069-0061-25 | Ropivacaine HClSomerset Pharma, LLC | 10 × 25 | 20 | 500 | $20.00 | ASP | Q1 2026 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 70069-0062-10 | Ropivacaine HClSomerset Pharma, LLC | 20 × 10 | 40 | 400 | $16.00 | ASP | Q1 2026 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 70069-0062-25 | Ropivacaine HClSomerset Pharma, LLC | 20 × 25 | 40 | 1,000 | $40.00 | ASP | Q1 2026 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 70069-0063-25 | Ropivacaine HClSomerset Pharma, LLC | 20 × 25 | 100 | 2,500 | $100.00 | ASP | Q1 2026 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 70069-0064-01 | Ropivacaine HClSomerset Pharma, LLC | 30 × 1 | 150 | 150 | $6.00 | ASP | Q1 2026 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 70069-0064-10 | Ropivacaine HClSomerset Pharma, LLC | 30 × 10 | 150 | 1,500 | $60.00 | ASP | Q1 2026 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 70069-0064-25 | Ropivacaine HClSomerset Pharma, LLC | 30 × 25 | 150 | 3,750 | $150.00 | ASP | Q1 2026 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 70069-0067-10 | Ropivacaine HClSomerset Pharma, LLC | 20 × 10 | 200 | 2,000 | $80.00 | ASP | Q1 2026 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|
| 70069-0067-25 | Ropivacaine HClSomerset Pharma, LLC | 20 × 25 | 200 | 5,000 | $200.00 | ASP | Q1 2026 – Q4 2026 | ListedRopivacaine Hydrochloride |
|---|